erve conduction studies changes in breast cancer patients undergoing chemotherapy and to study the protective effect of glutamine
Phase 3
- Conditions
- Health Condition 1: C50- Malignant neoplasm of breast
- Registration Number
- CTRI/2023/08/057147
- Lead Sponsor
- Jawaharlal Nehru Medical College Aligarh Muslim University Aligarh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Breast cancer diagnosed patients who are advised chemotherapy
Patients willing to participate after informed consent
Age 18 years and above
Normal performance status (ECOG 2)
Adequate renal and liver function
No co- morbidities
Exclusion Criteria
Hypothyroidism or hyperthyroidism
Diabetes mellitus
Previously diagnosed neuropathy
Pre existing autoimmune disease
Anti tubercular OR Anti viral therapy
Congestive heart failure, liver failure or renal failure
Chronic anemia
Chronic alcoholism, chronic smoking or drug abuse
Previously chemotherapy received
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method